跳到正文
原文
Endpoints News 生物医药· Elizabeth Cairns·· 8 天前AI 评分30

Blackstone 投资 15 亿美元支持 Pfizer 肥胖候选药 Berobe­natide 研发

Blackstone commits up to $1.5B for R&D of Pfizer's ex-Metsera GLP-1

AI 导读

Pfizer 获得投资集团 Blackstone 15 亿美元支持,用于其肥胖候选药 Berobe­natide 的研发。

正文

Pfiz­er has se­cured up to $1.5 bil­lion from the in­vest­ment group Black­stone Life Sci­ences to help pay for the de­vel­op­ment of its obe­si­ty can­di­date ber­obe­natide.

…

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news